January and February
January 29th - February 1st
Dubai World Trade Center
Please note that this website is not meant for consumers, as the information contained herein does not refer to finished products.
This website is available in various countries all over the world. As such, it may contain statements that are not applicable to your region.
Since 1982 Linnea has been committed to the development of high quality botanical APIs in our sustainable GMP certified facility in Ticino Switzerland. We improve the quality of life by manufacturing and supplying innovative cannabinoid ingredients worldwide while doing business responsibly.
Utilizing our decades of experience and expertise we created Linnea therapeutic cannabinoid solutions in 2014 starting with cannabinoid research and development and launching cannabinoid ingredients in 2016 using only GACP Compliant Cannabinoids, bringing our same innovative uncompromising approach to the pharmaceutical manufacturing of cannabinoids for customers around the globe.
Linnea’s cannabinoid isolates, cannabinoid extracts, bulk cannabinoid dilutions and cannabinoid white label solutions are available for the pharmaceutical, dietary ingredients and cosmetics industries worldwide.
GMP certified Pharma grade standardized cannabinoid extracts, 99% pure cannabinoid isolates, dilutions and white label cannabinoid solutions.
Cannabinoid standardized extracts, isolates, dilutions and white label solutions available for dietary supplements and food products.
Innovative cannabinoid ingredients containing Nioskin suitable for formulating skincare, personal care and cosmetic products.
Linnea is pleased to invite you to meet our team at these upcoming international events: